Deoxyadenosine metabolism in a human colon-carcinoma cell line (LoVo) in relation to its cytotoxic effect in combination with deoxycoformycin. 1998

V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici

We have assessed the intracellular metabolism of 2'-deoxyadenosine in a human colon-carcinoma cell line (LoVo), both in the absence and in the presence of deoxycoformycin, the powerful inhibitor of adenosine deaminase. The combination of 2'-deoxyadenosine and deoxycoformycin has been reported to inhibit the growth of LoVo cells in culture. In this paper we demonstrate that the observed toxic effect is strictly dependent on cell density. In the absence of deoxycoformycin, 2'-deoxyadenosine is primarily deaminated to 2'-deoxyinosine and then converted into hypoxanthine. In the presence of the inhibitor, the deoxynucleoside, in addition to a phosphorylation process, undergoes phosphorolytic cleavage giving rise to adenine. The conversion of 2'-deoxyadenosine to adenine might represent a protective device, emerging when the activity of adenosine deaminase is reduced or inhibited. There is much evidence to indicate that the enzyme catalyzing this process may be distinct from methylthioadenosine phosphorylase and S-adenosyl homocysteine hydrolase, which are the enzymes reported to be responsible for the formation of adenine from 2'-deoxyadenosine in mammals.

UI MeSH Term Description Entries
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D006131 Growth Inhibitors Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth ( Cell Growth Inhibitor,Cell Growth Inhibitors,Growth Inhibitor,Growth Inhibitor, Cell,Growth Inhibitors, Cell,Inhibitor, Cell Growth,Inhibitor, Growth,Inhibitors, Cell Growth,Inhibitors, Growth
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000227 Adenine Nucleotides Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015649 Pentostatin A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. 2'-Deoxycoformycin,CI-825,Co-Vidarabine,Deoxycoformycin,Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-,NSC-218321,Nipent,2' Deoxycoformycin,CI 825,CI825,NSC 218321,NSC218321

Related Publications

V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
October 2000, Journal of cellular biochemistry,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
July 1995, International journal of cancer,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
October 1989, Biochimica et biophysica acta,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
January 2003, Journal of biochemical and molecular toxicology,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
January 1994, Advances in experimental medicine and biology,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
August 2002, Toxicology in vitro : an international journal published in association with BIBRA,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
October 1986, Tumori,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
January 1993, Oncology research,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
July 2003, The Journal of surgical research,
V Bemi, and N Tazzni, and S Banditelli, and F Giorgelli, and R Pesi, and G Turchi, and A Mattana, and F Sgarrella, and M G Tozzi, and M Camici
October 2009, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Copied contents to your clipboard!